Literature DB >> 25194745

Loudness perception and speech intensity control in Parkinson's disease.

Jenna P Clark1, Scott G Adams2, Allyson D Dykstra3, Shane Moodie4, Mandar Jog5.   

Abstract

UNLABELLED: The aim of this study was to examine loudness perception in individuals with hypophonia and Parkinson's disease. The participants included 17 individuals with hypophonia related to Parkinson's disease (PD) and 25 age-equivalent controls. The three loudness perception tasks included a magnitude estimation procedure involving a sentence spoken at 60, 65, 70, 75 and 80 dB SPL, an imitation task involving a sentence spoken at 60, 65, 70, 75 and 80 dB SPL, and a magnitude production procedure involving the production of a sentence at five different loudness levels (habitual, two and four times louder and two and four times quieter). The participants with PD produced a significantly different pattern and used a more restricted range than the controls in their perception of speech loudness, imitation of speech intensity, and self-generated estimates of speech loudness. The results support a speech loudness perception deficit in PD involving an abnormal perception of externally generated and self-generated speech intensity. LEARNING OUTCOMES: Readers will recognize that individuals with hypophonia related to Parkinson's disease may demonstrate a speech loudness perception deficit involving the abnormal perception of externally generated and self-generated speech intensity.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Loudness perception; Parkinson's disease; Speech intensity

Mesh:

Year:  2014        PMID: 25194745     DOI: 10.1016/j.jcomdis.2014.08.001

Source DB:  PubMed          Journal:  J Commun Disord        ISSN: 0021-9924            Impact factor:   2.288


  12 in total

1.  Speech and voice disorders in patients with psychogenic movement disorders.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  J Neurol       Date:  2015-07-21       Impact factor: 4.849

2.  Neurophysiological investigation of auditory intensity dependence in patients with Parkinson's disease.

Authors:  Kim De Keyser; Miet De Letter; Patrick Santens; Durk Talsma; Dick Botteldooren; Annelies Bockstael
Journal:  J Neural Transm (Vienna)       Date:  2021-01-30       Impact factor: 3.575

3.  Loudness Perception of Pure Tones in Parkinson's Disease.

Authors:  Defne Abur; Ashling A Lupiani; Ann E Hickox; Barbara G Shinn-Cunningham; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2018-06-19       Impact factor: 2.297

4.  Aerodynamic findings and Voice Handicap Index in Parkinson's disease.

Authors:  Sergio Motta; Ugo Cesari; Mariano Paternoster; Giovanni Motta; Giuseppe Orefice
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-23       Impact factor: 2.503

5.  Drooling in Parkinson's Disease: Evidence of a Role for Divided Attention.

Authors:  Hannah Reynolds; Nick Miller; Richard Walker
Journal:  Dysphagia       Date:  2018-05-21       Impact factor: 3.438

6.  Evaluation of multi-feature auditory deviance detection in Parkinson's disease: a mismatch negativity study.

Authors:  Evelien De Groote; Annelies Bockstael; Dick Botteldooren; Patrick Santens; Miet De Letter
Journal:  J Neural Transm (Vienna)       Date:  2021-04-24       Impact factor: 3.575

7.  Impaired perceptual phonetic plasticity in Parkinson's disease.

Authors:  Christopher C Heffner; Emily B Myers; Vincent L Gracco
Journal:  J Acoust Soc Am       Date:  2022-07       Impact factor: 2.482

8.  Relationship Between Respiratory Sensory Perception, Speech, and Swallow in Parkinson's Disease.

Authors:  Karen W Hegland; Michelle Troche; Alexandra Brandimore
Journal:  Mov Disord Clin Pract       Date:  2019-02-20

9.  HiCommunication as a novel speech and communication treatment for Parkinson's disease: A feasibility study.

Authors:  Ellika Schalling; Helena Winkler; Erika Franzén
Journal:  Brain Behav       Date:  2021-05-04       Impact factor: 2.708

10.  Speech treatment in Parkinson's disease: Randomized controlled trial (RCT).

Authors:  Lorraine Ramig; Angela Halpern; Jennifer Spielman; Cynthia Fox; Katherine Freeman
Journal:  Mov Disord       Date:  2018-09-28       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.